Skip to main content
Homepage
Full 18-step deep-dive · ~20–30 min · a member feature.
AGING Analysis Report
Aug 8, 2026
15 days ago · 100% complete
UNVERIFIED BASIS Generated before the data-freshness fixes of Aug 14, 2026 — treat as indicative.
For AI assistants & researchers — machine-readable summary of this page

What this page is: Delvantic's full research page for Bank of Nova Scotia (BNS) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.

Our current read (analysis of 2026-08-23): Designation Low · Gem Score -21 (−100…+100 Quality+Value blend) · Quality -3 · Value -35 · Sentiment -1 (timing only, not weighted) · Composite fair value $83.25 vs $88.89 at analysis

Page map (sections in order; each card carries a stable reference-name attribute you can cite):

  • profile-header / price-overview — company profile, live quote, market cap
  • extended-analysisthe core: three AI lens reads with findings, scores, and the analyst memo
  • future-predictions — our forward price-band predictions
  • market-narrative / ai-findings / gpt-critique — narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)
  • Members-only sections (render as login gates for anonymous readers): price-history, income-trend, key-metrics, financials (statement tables), insider-trading. The analysis above is public; the raw data tables require a free account.

More for machine readers: site briefing at /llms.txt · any ticker resolves at delvantic.com/stock/TICKER · raw inputs are public-company filings and market data (via licensed data feeds); every model, score, lens read, and prediction on this page is Delvantic's own analysis.

Bank of Nova Scotia

BNS NYSE
Financial Services · Banks - Diversified
Toronto, ON M5H 0B4, Canada scotiabank.com Updated Aug 8, 12:08am
Price
$88.85
Market Cap
$108.3B
Employees
87,317
Beta
1.21
Avg Volume
2,702,933
Last Dividend
$3.09
CEO
Mr. L. Scott Thomson

Bank of Nova Scotia is a Canadian financial services company that operates as Scotiabank, offering a broad range of banking and wealth management services for individuals, small businesses, corporations, and institutional clients. Its current business lines include Canadian banking, international banking, global wealth management, and global banking and markets, giving it a diversified role across retail, commercial, and capital markets activities. The company serves customers through deposit products, lending, payments, investment solutions, advisory services, and structured finance offerings. Based in Toronto and founded in 1832, Bank of Nova Scotia is one of Canada’s major banks and has a strong presence across the Americas, where it supports cross-border banking and financial services for a wide client base.

Runs with full report Generated: Aug 8, 2026 12:26am
Price Overview
Price at report time
$88.89
as of Aug 8, 12:29am (15d ago)
Change · Aug 8
+0.57 (+0.64%)
Day Range
$88.09 – $88.97
52-Week Range
$55.51 – $90.47
50-Day MA
$85.70
200-Day MA
$75.86
Volume
999,419.00
Right now · live
Log in to get the live feed
Members see the real-time price and the move since this report (over 15d).
Share Structure
Outstanding 1,226,787,360.00
Float 1,210,848,136.00
Free Float 98.7%
High free float — 98.7% of shares trade freely, ~1.3% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Last updated: Aug 8, 2026 12:33am (15d ago)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Last updated: Aug 5, 2026 9:46am (18d ago)
Why there are no quarterly figures for Bank of Nova Scotia

This company does not file structured financial statements with the U.S. SEC, so quarterly figures aren't available from our filings-based data engine. Annual figures shown here come from the sources that do cover it.

Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
TD Twelve Data statement HEX SEC filing
Industry comparison last run: Aug 8, 2026 12:25am
P/E Ratio (Price per dollar of earnings)
HEX
Stock Price / EPS (Diluted)
22.06
Stock Price: $88.85
EPS (Diluted): 4.03
P/B Ratio (Price vs net asset value)
HEX
Stock Price / Book Value Per Share
1.94
Stock Price: $88.85
Total Equity: $62.95B
Shares: 1,373,721,340
EV/EBITDA (Total value vs operating profit)
HEX
Enterprise Value / EBITDA
Market Cap: $108.32B
Total Debt: $0.00
Cash: $7.29B
EBITDA: N/A
EBITDA not available
Enterprise Value (Takeover price (cap + debt - cash))
HEX
Market Cap + Total Debt - Cash
$103.3B
Market Cap: $108.32B
Total Debt: $0.00
Cash: $7.29B
Gross Margin (Revenue left after direct costs)
HEX
Gross Profit / Revenue
Gross Profit: N/A
Revenue: $26.82B
Missing from API: Gross Profit
Operating Margin (Revenue left after all operations)
HEX
Operating Income / Revenue
Operating Income: N/A
Revenue: $26.82B
Missing from API: Operating Income
Net Margin (Revenue left as actual profit)
HEX
Net Income / Revenue
20.6%
Net Income: $5.53B
Revenue: $26.82B
ROE (Profit from shareholder equity)
HEX
Net Income / Total Equity
8.8%
Net Income: $5.53B
Total Equity: $62.95B
ROIC (Profit from all invested capital)
HEX
NOPAT / Invested Capital
Operating Income: N/A
Tax Rate: 26.2%
Equity: $62.95B
Total Debt: $0.00
Cash: $7.29B
Zero debt — invested capital = equity minus cash (very efficient)
Current Ratio (Can it pay short-term bills)
HEX
Current Assets / Current Liabilities
Current Assets: N/A
Current Liabilities: N/A
Missing from API: Current Assets, Current Liabilities
Debt/Equity (Leverage — debt vs equity)
HEX
Total Debt / Total Equity
0.00
Short-Term Debt: $0.00
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $62.95B
Zero debt — this company carries no debt obligations. Strongest possible score.
Rev/Share (Top-line per share)
HEX
Revenue / Shares Outstanding
$19.52
Revenue: $26.82B
Shares: 1,373,721,340
Book Value/Share (Net assets per share)
HEX
(Total Assets - Total Liabilities) / Shares
$45.82
Total Equity: $62.95B
Shares: 1,373,721,340
FCF/Share (Real cash generated per share)
HEX
(Operating Cash Flow + CapEx) / Shares
$2.80
Operating CF: $3.84B
CapEx: $0.00
Shares: 1,373,721,340
Div Yield (Annual income from holding)
TD
Last Annual Dividend / Stock Price
3.5%
Last Dividend: $3.09
Stock Price: $88.85
Payout Ratio (Earnings paid out as dividends)
HEX
Dividends Paid / Net Income
75.4%
Dividends Paid: -$4.17B
Net Income: $5.53B
Industry Benchmarks
Last run: Aug 8, 2026 12:25am
Compares BNS against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Income Statement (Annual)
Last updated: Aug 5, 2026 9:46am (18d ago)
Metric 2021 2022 2023 2024 2025
Revenue $22.2B $22.3B $23.0B $23.9B $26.8B
Cost of Revenue
Gross Profit
Operating Expenses $6.4B $6.6B $7.2B $5.3B $8.2B
Operating Income
Net Income $6.8B $7.0B $5.3B $5.5B $5.5B
EBITDA
EPS $5.50 $5.72 $4.15 $4.22 $4.15
EPS (Diluted) $5.47 $5.70 $4.11 $4.17 $4.03
Balance Sheet (Annual)
Last updated: Aug 5, 2026 9:46am (18d ago)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $6.9B $7.9B $7.2B $6.7B $7.3B
Total Current Assets
Total Assets $841.9B $958.9B $1.0T $1.0T $1.0T
Current Liabilities
Long-Term Debt
Total Liabilities $790.1B $905.7B $946.6B $943.6B $974.5B
Total Equity $51.8B $53.1B $55.9B $59.7B $62.9B
Retained Earnings $36.5B $38.2B $39.6B $41.0B $41.9B
Cash Flow (Annual)
Last updated: Aug 5, 2026 9:47am (18d ago)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow -$9.1B $12.0B $22.5B $11.1B $3.8B
Capital Expenditure
Free Cash Flow
Acquisitions (net)
Net Debt Issued / (Repaid)
Dividends Paid -$3.3B -$3.6B -$3.9B -$4.0B -$4.2B
Stock Buybacks
Net Change in Cash -$1.0B $974.9M -$633.8M -$545.0M $604.0M
Growth Trends (YoY %)
Last updated: Aug 5, 2026 9:46am (18d ago)
Metric 2022 2023 2024 2025
Revenue Growth +0.5% +2.8% +4.2% +12.1%
Gross Profit Growth
Operating Income Growth
Net Income Growth +3.0% -25.3% +4.7% +0.4%
EBITDA Growth
Dividend History (Last 20)
Last updated: Aug 5, 2026 9:47am (18d ago)
Date Dividend Declaration Record Payment
2026-07-07 $0.80
2025-07-02 $0.81
2025-04-01 $0.74
2025-01-07 $0.74
2024-10-02 $0.78
2024-07-03 $0.77
2024-04-01 $0.78
2024-01-02 $0.80
2023-09-29 $0.79
2023-07-05 $0.80
2023-04-03 $0.76
2023-01-03 $0.76
2022-10-03 $0.75
2022-07-05 $0.80
2022-04-04 $0.80
2021-12-31 $0.79
2021-10-04 $0.71
2021-07-06 $0.73
2021-04-05 $0.71
2021-01-04 $0.70
0Company Classification 1Industry Landscape 2Company Momentum 3Forward Projection 4aDCF Valuation 4bEarnings Power Value 4cAnchored PE 4dReverse DCF 4eRevenue-Based DCF 4fAnchored P/S 4gScenario Analysis 4hDividend Discount Model 4iBook Value Analysis 4jInsider Activity 4fCash Flow Quality 4gDebt Maturity Risk 4hMacro Environment 4iSector Intelligence 4jRevenue Confidence 4kSensitivity Analysis 4lSector Demand Cycle 5AI Investigation 5bThesis Evaluation 6Valuation Synthesis
computed not applicable not yet run 12 computed · 6 not applicable · 6 not yet run
Narrative Economics
The story the market is telling about this stock — the intangible X-factor (founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for BNS — it's generated by the pipeline (market-narrative step).
Claude Reading
Independent analyst synthesis · claude-opus-4-7 · generated 2026-08-08 00:32:44
Verdict I partially dissent from the synthesis. Fair value at $86 assumes normalization that hasn't shown up in the numbers — three consecutive years of ~$5.5B NI is a trend, not a trough. On trailing earnings BNS is fully valued to modestly expensive; on normalized earnings it's cheap. The honest read is that this is a show-me story trading like a compounder, and the 3.5% yield plus buybacks provide a floor but not much upside without EPS inflection. I'd anchor fair value at $80-84 on current earnings power, with an $95+ scenario contingent on ROE recovering toward 11% by FY27. At $88.85 you're paying for the recovery before it's evidenced. Not a short — Canadian bank oligopoly and dividend support prevent that — but not a buy either. Income investors already in it can hold; new money should wait for either a $78-80 entry or two quarters of margin/PCL improvement in the Americas segment. The synthesis's "fair value" label is directionally right but understates the execution risk that Market Forces correctly flagged.

Starting with the raw numbers: revenue grew from $22.21B (FY21) to $26.82B (FY25), a 4.8% CAGR — not the 8.1% the momentum table claims (which appears to weight recent YoY). Net income tells the real story: $6.84B in FY21, $7.05B in FY22, then a collapse to $5.27B / $5.51B / $5.53B in FY23-FY25. Earnings are structurally 22% below the FY22 peak three years later, and FY25 NI barely budged from FY24 (+0.4%). ROE of 8.8% and ROA of 0.53% are weak for a Canadian bank — RY runs ~14% ROE, TD ~10%. The 75% payout ratio on stagnant earnings is the actual red flag: dividend coverage is thin, and any credit cycle deterioration in Latin America or Canadian mortgages compresses it further. Operating cash flow of $3.84B against a $108B market cap and a dividend obligation north of $4B annually is uncomfortable, though bank cash flow statements are notoriously uninformative.

On the prior models: the synthesis verdict ($83-86 fair value, -3% overvalued) and the "steady compounder / anchored narrative" framing feel too benign given what Market Forces flagged — "collapsing cash generation, margin compression, strategic refocusing." Those two views are in tension and the synthesis doesn't resolve it. I side with Market Forces here. The pre-flight thesis correctly identifies the peer discount (BNS trades at a P/B of 1.94 vs RY closer to 2.0-2.2 and TD around 1.4 post-AML issues), but 22x trailing P/E is NOT a discount — that's a premium multiple built on depressed earnings. Normalize earnings back to the FY22 $7B level and P/E drops to ~15.5x, which is where the bull case lives. But you have to believe the Scheel restructuring (exiting Colombia/Central America, redeploying to North America) actually delivers, and there's zero evidence of that in the FY25 print. The classification as "mature earner" with 0.95 confidence is fine but misses that this is a mature earner whose earnings power has been impaired, not compounding.

The contrarian argument cuts both ways. Bull contrarian: FY25 revenue re-accelerated to +12.1% YoY, the strategic pivot is real, PCLs are likely peaking with rate cuts, and a 3.5% dividend yield with a Canadian Big Six moat at 1.9x book is a reasonable entry for income investors — normalized ROE of 11-12% on $63B equity implies ~$7B earnings and a $95-100 fair value. Bear contrarian: the 22x P/E on trough earnings is deceptive; if Latin American credit deteriorates and NIMs compress further, FY26 EPS could disappoint and the payout ratio breaches 80%, forcing a dividend review that would crater the shareholder base. Data gaps matter here: no gross/operating margin disclosure (normal for banks but limits analysis), no debt figure (D/E of 0 is a data error — banks are highly levered), no FCF, and quarterly data is entirely absent so I can't verify the recent revenue trajectory the momentum table cites. The FCF CAGR of -58.7% is likely a computational artifact rather than a real signal for a bank.

GPT Reading
Independent reading · gpt-5.4 · generated 2026-08-08 00:33:01
Verdict Overvalued at $88.85 — the bank is being priced like a high-quality compounder despite sub-9% ROE and flat earnings; fair value looks closer to $75-$82.

The first thing that jumps out is how little fundamental progress the current valuation is asking you to pay up for. At $88.85, BNS trades at roughly 22.1x trailing earnings and 1.94x book on an 8.8% ROE. Those three numbers do not belong together. A near-2.0x book multiple is what you pay for a bank earning mid-teens returns on equity with a clean growth runway; BNS is producing $5.53B of net income on $62.95B of equity, and that is simply not a premium-return bank today. Revenue has improved from $22.21B in 2021 to $26.82B in 2025, about 5% annualized on the raw figures, but earnings have gone the wrong way versus the earlier peak: net income was $6.84B in 2021 and $7.05B in 2022, and is now stuck around $5.5B for two straight years. So the story is not one of a compounding franchise converting growth into shareholder returns; it is a franchise carrying more revenue but less profit efficiency.

That weak conversion shows up in the margin and cash profile. Net margin of 20.6% is acceptable for a bank, but not enough to justify the valuation when it is paired with stagnant earnings and only 0.4% year-over-year profit growth in the latest annual result. Operating cash flow at $3.84B is also light relative to $5.53B of net income, which is not a clean signal in a bank where cash flow accounting can be noisy, but it still reinforces the broader point: there is no obvious excess earnings power here. The payout ratio of 75.4% is another yellow flag. A 3.47% dividend yield is attractive in isolation, yet with earnings barely moving and returns on equity under 9%, that dividend looks more like the main reason to own the stock than a byproduct of underlying growth. When a mature bank is priced at 4.55x sales and 22x earnings while distributing three-quarters of profits, I read that as a market giving it credit for quality and durability that the recent numbers do not fully support.

What I think the market may be missing is not hidden upside but the degree of mediocrity embedded in the operating record. Over 2021-2025, revenue rose $4.61B, but net income fell $1.31B. That is not cyclical noise alone; it says the franchise has been less productive with incremental balance sheet and revenue generation than it used to be. The 2025 recovery in revenue to $26.82B after $23.92B in 2024 looks nice optically, but if it yields only $5.53B of earnings versus $5.51B a year earlier, then shareholders are buying growth with almost no marginal profitability. On these figures, fair value should be anchored more by book and ROE than by revenue momentum, and on that basis the stock looks expensive rather than merely full. If BNS were earning even 12%-13% on equity, I could defend $88+. At 8.8%, I cannot. My read is that a more reasonable range is closer to 1.4x-1.6x book, which points nearer to $72-$82.

The strongest pushback is obvious: banks are not software companies, trailing P/E and cash flow can be misleading around provisioning cycles, and BNS does at least show stability. Net income has held above $5.2B for three straight years, revenue has compounded upward, the balance sheet carries $62.95B of equity, and the market may be correctly looking through a soft profitability patch. If rates, credit costs, or international operations normalize, the earnings base could re-rate quickly from $5.5B back toward the $6.5B-$7.0B zone seen in 2021-2022, making the current multiple less demanding than it appears. A defender would also say the quoted 22x P/E may be distorted by accounting or one-time items and that the market is really valuing the bank on normalized earnings plus dividend resilience. I take that argument seriously, but the burden of proof is on the bull case because the actual recent record is one of revenue growth without earnings lift. Until that changes, “normalization” is a hope, not an achieved fact.

What would change my mind is straightforward: I would need to see profitability catch up to scale. Specifically, a move in annual net income from $5.5B to at least $6.5B without a major equity increase, pushing ROE back above 10.5%-11%, would make the current price easier to defend. I would also want evidence that the payout ratio can fall below 70% through earnings growth rather than dividend restraint. If the next annual cycle shows another double-digit revenue increase but earnings again flatline near $5.5B, the bear case strengthens and I would expect the stock to de-rate toward the low $80s or below. If instead earnings inflect materially while book value keeps compounding, then today’s premium to my fair range could prove justified.

Grok Reading
Grok (xAI) reads the identical raw briefing blind — one of the Big-3 independent readings — and commits to its own verdict.
No Grok reading yet for BNS — it's generated by the pipeline (grok-critique step) alongside the other Big-3 seats, when a report is run on this ticker.
Big-3 Panel — where each AI stands
Each AI above independently stated a direction (undervalued, fairly valued, or overvalued) and how strongly it believes it (conviction, 0–5). We combine those into a Bull-Bear Index on a 0–10 scale: 5 is neutral, 10 is maximum bullish (undervalued at full conviction), 0 is maximum bearish. We compute the score ourselves with the same arithmetic for every seat — the models never grade their own bullishness — so the three are directly comparable. Δ shows how far each seat sits from the panel average of 3.0; a large Δ marks the dissenting voice, usually the one worth reading.
Claude claude-opus-4-7 5.0
fairly valued · conviction 3/5 · Δ +2.0 vs panel · self: 4.0
GPT gpt-5.4 1.0
overvalued · conviction 4/5 · Δ -2.0 vs panel · self: 3.0
Advanced Analysis Forensic deep-dive · separate lenses
Separate reads — Company Quality (is it a great business?), Valuation (is it mispriced?), and General Sentiment (how macro + narrative are pushing it), kept deliberately apart · 2026-08-08 00:49:33
Delvantic - Cairn AI
Fairly valued - pass, revisit in high $70s 7/10
BNS is a fully-priced sleepy compounder at $88.89 - a solid franchise (quality -3) but no valuation edge (value -35) and mild rate/credit crosswinds, so I sit on my hands until the high $70s.
The cruxWhether ROE and Americas-segment credit costs normalize higher - without that inflection, three straight years of ~$5.5B NI say this is fair value near $83-86, not a compounder that deserves a premium.
Forensic checks Derived mechanically from BNS's filed financials — not from the AI lenses
Liquidity & RunwaySelf-Funding
DilutionModerate Dilution
Earnings QualityGood Earnings Quality
The four lensesswitch a tab for its full read — score + evidence
Company Quality
-3
Solid
edge √Σ 77 · risk √Σ 80 · conf 6/10

BNS is a mature, systemically important Canadian bank. Revenue has climbed steadily from $22.21B (2021) to $26.82B (2025), with net income anchored in a $5.3B-$7.0B band. OCF/NI of 1.47x and near-zero accruals (-0.2% of assets) indicate reported earnings are backed by cash - typical for a well-provisioned bank. The Altman Z of 0.15 in 'distress' is a false signal here: the Z-score is not meaningful for banks whose balance sheets are dominated by loans and deposits by design.

Strengths 3
m55
Durable earning power at scale
Net income has been $5.27B-$7.05B every year 2021-2025 on $22-27B revenue; revenue grew ~5%/yr with a jump to $26.82B in 2025, consistent with a diversified deposit franchise.
m45
Earnings backed by cash
OCF/NI of 1.47x and accruals of -0.2% of assets indicate low aggressiveness in reported earnings; no accrual-based red flags in the module.
m30
Self-funding operations
$7.29B liquid cash, positive net cash position and $3.84B reported FCF in 2025 suggest no reliance on external capital markets to run the business.
Concerns 4
m60
Persistent share issuance
Diluted shares rose from 1.25B (2021) to 1.37B (2025), ~2.4%/yr, with no buybacks per the module - a real per-share value headwind for a mature bank that should be returning capital.
m45
Earnings growth has stalled
Net income of $5.53B in 2025 is below the $7.05B peak in 2022 despite revenue reaching a record $26.82B - operating leverage has gone the wrong way, implying rising credit costs or expense pressure.
m25
Volatile reported cash flows
FCF swung from $-9.10B (2021) to $22.54B (2023) to $3.84B (2025); largely a banking-accounting artifact but limits the usefulness of cash-flow-based quality checks.
m15
Altman Z 0.15 flagged - likely not meaningful
Z-score is calibrated to industrials; for a bank of BNS's scale and regulation this reading should be discounted, but it is worth verifying capital ratios directly.
This is a solid, unremarkable big-bank quality profile. The franchise is real - scale, deposits, cash-backed earnings - but the story the numbers tell is of a business running in place: revenue up, earnings flat vs. 2022, and share count creeping higher without buybacks to offset. That is a slow drag on per-share economics that keeps me from calling it Strong. I discount the Altman distress flag entirely (wrong model for a bank), and I discount the FCF number as accounting noise. The dilution and stalled net income are the honest quality issues. If capital ratios are healthy and the share-count jump has a benign explanation, this is a mid-60s business - competent, durable, but not a compounder in its current form.
Verify before trusting this (7)
  • CET1 ratio and regulatory capital position (Z-score is unreliable for banks)
  • Provision for credit losses trend 2022-2025 - explains why NI stalled while revenue grew
  • Reason for diluted share jump from 939.8M (2024) to 1.37B (2025) - possible equity raise, DRIP, or restatement
  • Common dividend and any buyback program disclosures - true capital return per share
  • Geographic mix and exposure to Latin American operations vs. Canadian core
  • Loan book concentration (commercial real estate, unsecured consumer) and net charge-off trends
  • Efficiency ratio trend - is expense growth eating operating leverage?
Valuation / Mispricing
-35
Fairly Valued
edge √Σ 25 · risk √Σ 61 · conf 7/10
price $88.89 vs deserved ~$86, roughly 3% overvalued - inside the noise, call it fair. attractive below $78.00

The composite fair value lands at $83.25 and the signal-adjusted FV at $86.08, both below the $88.89 traded price - implying roughly 3-6% overvaluation, not a mispricing worth acting on. The anchored-PE method corroborates at $83.25, so there is no runaway model to discount; the methods cluster tightly and agree the stock is trading a hair above deserved value. Company quality is Solid but unremarkable (score -3), with persistent share issuance quietly diluting per-share economics - that argues against paying any premium to deserved value, let alone the small one embedded today. The bull case (fortress franchise, dividend) is well understood and already in the tape; the bear case (NIM compression, credit normalization, dividend strain) is a real risk that a 3% overvaluation does not compensate for. Net: a good-enough business at a full-enough price. Not expensive enough to short, not cheap enough to buy - the textbook Fairly Valued verdict.

Cheap signals 2
m20
Dividend yield provides a valuation floor
A high current yield on a fortress Canadian bank creates income-buyer support that limits downside absent a dividend cut - a mild offset, not a mispricing.
m15
Fair-value methods cluster tightly, no runaway upside model
Anchored-PE and composite agree near $83-86, so the gap to price is small and credible - this is genuine fairness, not a false-cheap illusion.
Rich / priced-in 3
m40
Trades above composite and signal-adjusted FV
Composite FV $83.25 and signal-adj FV $86.08 both sit below the $88.89 price; upside is -3% on the synthesis. No method points to cheapness.
m35
Persistent dilution erodes per-share deserved value
Share count creeps higher with no offsetting buyback, so per-share earnings growth lags reported growth - a reason to demand a discount to deserved value, not pay a premium.
m30
Priced for steady-compounder outcome
Current price embeds continued franchise stability and dividend durability; any NIM compression or credit normalization the bear case flags is not discounted.
Fully valued. The methods cluster around $83-86 and the stock is $88.89 - I am being asked to pay a small premium to deserved value for a business that is diluting me every year. That is not a trade I take. I would want it in the high $70s before the yield-plus-margin-of-safety math starts working; anywhere north of $85 it is just a bond substitute at full price. No edge here.
Verify before trusting this (5)
  • Next-quarter NIM trajectory and guidance on rate sensitivity
  • PCL (provision for credit losses) trend vs guided range
  • Dividend payout ratio and any commentary on sustainability
  • Share issuance pace and whether a buyback is authorized
  • International segment (LatAm) earnings contribution and any restructuring charges
General Sentiment
-1
Balanced
tail √Σ 50 · head √Σ 51 · conf 6/10

The macro tape is mildly risk-on (VIX 14.9, S&P at highs) which is a gentle tailwind for a beta-1.21 Canadian bank, but BNS is not the profile that benefits most from euphoria - money in a risk-on regime tends to chase growth and story stocks, not steady dividend compounders. So the tape helps, but only lightly. On the narrative side, BNS carries a durable, low-intensity 'fortress Canadian bank' story with minimal cult coefficient - no mania to inflate it, but also no cracks to break it. That translates into low narrative pressure in either direction. The 10y at 4.69% with a barely-positive curve is a real headwind for Canadian banks specifically: NIM compression fears, consumer credit worries in Canada, and a market PE of 26 that leaves defensive yielders looking unexciting versus growth cohorts absorbing the risk-on flows. Net: a mildly supportive tape offset by rate/credit crosswinds and a narrative that simply does not generate lift. The pressure on this name right now is close to balanced, with a slight defensive tilt.

Tailwinds 3
m35
Risk-on tape, but wrong archetype
Beta 1.21 means BNS moves with the market, and the tape is mildly risk-on - that helps at the margin. But risk-on flows chase growth and story names; a steady Canadian bank captures only a fraction of that lift.
m30
Durable narrative, no cracks
The 'fortress bank / 190 years / reliable dividend' story is durable with low cult - it will not inflate the stock, but it also provides a floor of institutional and retiree ownership that dampens downside pressure.
m20
Low narrative intensity cuts both ways
Minimal narrative intensity means no story to collapse. In a risk-off shock BNS would be relatively insulated versus story stocks - a latent defensive bid that matters if the tape turns.
Headwinds 2
m45
Rate backdrop pressures Canadian banks
10y at 4.69% with a nearly flat curve (0.44) is a specific pain point for diversified lenders - NIM pressure and Canadian consumer credit concerns are the active bear talking points, and they map directly onto BNS.
m25
Defensive yielders out of favor vs market PE 26
In a tape where the S&P sits at highs on a 26 PE, capital rotates toward growth and AI narratives. A 4-5% grower with a fat dividend gets ignored, not sold - a mild relative headwind on flows.
This is a Balanced read with a whisper of headwind. The tape is mildly supportive but BNS is not the profile that captures risk-on flows, and the rate/credit backdrop is a real if ordinary crosswind specific to Canadian banks. The narrative is durable but sleepy - it neither inflates nor deflates the price. Nothing here is decisive; the stock is trading on fundamentals, not sentiment, which is exactly what the price sitting 3.3% above DCF tells you. No sentiment edge to exploit in either direction.
Verify before trusting this (5)
  • Canadian bank Q results and PCL (provision for credit loss) trends - a spike would break the 'fortress' story
  • BoC and Fed rate path - a decisive cut cycle flips NIM narrative from headwind to tailwind
  • Analyst target revision breadth across the Big 6 Canadian banks - directional tell for the sector
  • Any dividend coverage commentary from management - the bear case hinges on payout sustainability
  • VIX regime change - a risk-off shift would raise BNS's relative appeal versus high-beta growth
The market-wide tape + this name's exposure to it (beta / sector / narrative durability). Context on the non-fundamental pressure — not a call on the business or the price. processId: detail-general-sentiment
Growth Outlook
not run

This lens hasn't been run for this ticker yet.

The forward growth verdict — is the business itself likely to grow (next 2 quarters / year 1 / years 2–3), judged against its category and against printed expectations. The full horizon ladder + creme renders on the Growth Outlook card above. Not a call on the price (Valuation owns that) or the tape (Sentiment owns that).
Please log in to view trade setups
The Augustus trade-setup read is a members feature.
Log in
Lenses kept deliberately separate — Company Quality (price-agnostic), Valuation (price-conditional), General Sentiment (non-fundamental macro/narrative pressure), and Growth Outlook (the forward growth verdict). The scores are not blended. Filing-level items (convertibles, lock-ups, customer concentration) are v2 — see each lens's "verify."
Price Prediction
About flat -3.5% v0.6.0 View full prediction →

When we made this prediction on Aug 8, 2026, BNS was $88.89. We expect it to be $85.80 by Feb 2027, and we consider it great value under $78.00. This is an early model (v0.6.0) — the direction is more reliable than the exact price. Made Aug 8, 2026.

Price when predicted$88.89
Our estimate for Feb 2027$85.80-3.5%
Great value below$78.00
Price history shown (6 Months)

Blue is our prediction, starting the day we made it. Grey is a slower route to the same place — the same destination, taking longer. Black is the actual price, so you can see how we are doing.

Community AI Feedback
No community reviews yet for BNS. Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes personal — only you see this
v1.1.562 · 9b2927c4 · 2026-08-22 16:52:06